GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Falling Comet
2459.5000 -14.10 (-0.57%)
NSE Jan 01, 2026 13:04 PM
Volume: 29,029
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
02 Aug 2025
2459.50
-0.57%
buy
by Motilal Oswal
Target: 3000 | Upside : 22.0%
Motilal Oswal
GlaxoSmithKline Pharmaceuticals (GLXO) delivered lower-than-expected revenue/EBITDA (8%/5% miss) in 1QFY26.
 
Number of FII/FPI investors decreased from 390 to 362 in Sep 2025 qtr
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Will the smallcap investor run out of patience in 2026?
The Baseline | 01 Jan 2026, 11:23AM
Market closes higher amid strong buying in steel stocks
Trendlyne Marketwatch | 31 Dec 2025, 04:01PM
2025 turns selective on returns: Themes outperform while headline indices stall
The Baseline | 31 Dec 2025, 03:05PM